Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Human NK Cell Isolation Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Human NK Cell Isolation Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 153 Pages
Report ld: 4815977
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human NK Cell Isolation Kit Market Size(US$)
CAGR 2025-2031
6.5%
Market Size,2031
USD 470
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 322 million
Market Forecast in 2031(Value)
US$ 470 million
CAGR
6.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The Human NK Cell Isolation Kit is designed to magnetically isolate NK cells from a complex immune cell population. The kit is optimized for the isolation of CD56+CD3- cells from normal human peripheral blood mononuclear cells (PBMCs). The cells are incubated with a cocktail of antibodies and then bound to magnetic beads. They are then placed on a magnet for quick and easy separation. When placed on the magnet, non-NK cells will be fixed to the side of the tube, while NK cells will remain in suspension and can be easily removed for downstream applications.
From a downstream perspective, Research Institute accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Human NK Cell Isolation Kit leading manufacturers including BPS Bioscience, Miltenyi Biotec, Novus Biologicals, STEMCELL Technologies, Thermo Fisher Scientific, RWD, Xinxie Biotechnology, Jinzhun Biotechnology, R&D Systems, BioLegend, etc., dominate supply; the top five capture approximately % of global revenue, with BPS Bioscience leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human NK Cell Isolation Kit market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- BPS Bioscience
- Miltenyi Biotec
- Novus Biologicals
- STEMCELL Technologies
- Thermo Fisher Scientific
- RWD
- Xinxie Biotechnology
- Jinzhun Biotechnology
- R&D Systems
- BioLegend
- Proteintech Group
- Stemery
- Creative Bioarray
- LubioScience
- Immocell
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 1 x 10^8 Cells
- 1 x 10^9 Cells
- Other
Segment by Application
- Research Institute
- School
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Human NK Cell Isolation Kit study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report?
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Human NK Cell Isolation Kit: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human NK Cell Isolation Kit Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 1 x 10^8 Cells
1.2.3 1 x 10^9 Cells
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Human NK Cell Isolation Kit Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Research Institute
1.3.3 School
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human NK Cell Isolation Kit Revenue Estimates and Forecasts 2020-2031
2.2 Global Human NK Cell Isolation Kit Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Human NK Cell Isolation Kit Sales Estimates and Forecasts 2020-2031
2.4 Global Human NK Cell Isolation Kit Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Human NK Cell Isolation Kit Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Human NK Cell Isolation Kit Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 1 x 10^8 Cells Market Size by Manufacturers
3.5.2 1 x 10^9 Cells Market Size by Manufacturers
3.5.3 Other Market Size by Manufacturers
3.6 Global Human NK Cell Isolation Kit Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human NK Cell Isolation Kit Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Human NK Cell Isolation Kit Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human NK Cell Isolation Kit Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Human NK Cell Isolation Kit Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Human NK Cell Isolation Kit Sales and Revenue by Type (2020-2031)
6.4 North America Human NK Cell Isolation Kit Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human NK Cell Isolation Kit Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Human NK Cell Isolation Kit Sales and Revenue by Type (2020-2031)
7.4 Europe Human NK Cell Isolation Kit Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human NK Cell Isolation Kit Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Human NK Cell Isolation Kit Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Human NK Cell Isolation Kit Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Human NK Cell Isolation Kit Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Human NK Cell Isolation Kit Sales and Revenue by Type (2020-2031)
9.4 Central and South America Human NK Cell Isolation Kit Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human NK Cell Isolation Kit Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Human NK Cell Isolation Kit Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Human NK Cell Isolation Kit Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human NK Cell Isolation Kit Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BPS Bioscience
11.1.1 BPS Bioscience Corporation Information
11.1.2 BPS Bioscience Business Overview
11.1.3 BPS Bioscience Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.1.4 BPS Bioscience Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BPS Bioscience Human NK Cell Isolation Kit Sales by Product in 2024
11.1.6 BPS Bioscience Human NK Cell Isolation Kit Sales by Application in 2024
11.1.7 BPS Bioscience Human NK Cell Isolation Kit Sales by Geographic Area in 2024
11.1.8 BPS Bioscience Human NK Cell Isolation Kit SWOT Analysis
11.1.9 BPS Bioscience Recent Developments
11.2 Miltenyi Biotec
11.2.1 Miltenyi Biotec Corporation Information
11.2.2 Miltenyi Biotec Business Overview
11.2.3 Miltenyi Biotec Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.2.4 Miltenyi Biotec Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Miltenyi Biotec Human NK Cell Isolation Kit Sales by Product in 2024
11.2.6 Miltenyi Biotec Human NK Cell Isolation Kit Sales by Application in 2024
11.2.7 Miltenyi Biotec Human NK Cell Isolation Kit Sales by Geographic Area in 2024
11.2.8 Miltenyi Biotec Human NK Cell Isolation Kit SWOT Analysis
11.2.9 Miltenyi Biotec Recent Developments
11.3 Novus Biologicals
11.3.1 Novus Biologicals Corporation Information
11.3.2 Novus Biologicals Business Overview
11.3.3 Novus Biologicals Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.3.4 Novus Biologicals Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novus Biologicals Human NK Cell Isolation Kit Sales by Product in 2024
11.3.6 Novus Biologicals Human NK Cell Isolation Kit Sales by Application in 2024
11.3.7 Novus Biologicals Human NK Cell Isolation Kit Sales by Geographic Area in 2024
11.3.8 Novus Biologicals Human NK Cell Isolation Kit SWOT Analysis
11.3.9 Novus Biologicals Recent Developments
11.4 STEMCELL Technologies
11.4.1 STEMCELL Technologies Corporation Information
11.4.2 STEMCELL Technologies Business Overview
11.4.3 STEMCELL Technologies Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.4.4 STEMCELL Technologies Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 STEMCELL Technologies Human NK Cell Isolation Kit Sales by Product in 2024
11.4.6 STEMCELL Technologies Human NK Cell Isolation Kit Sales by Application in 2024
11.4.7 STEMCELL Technologies Human NK Cell Isolation Kit Sales by Geographic Area in 2024
11.4.8 STEMCELL Technologies Human NK Cell Isolation Kit SWOT Analysis
11.4.9 STEMCELL Technologies Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Corporation Information
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.5.4 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales by Product in 2024
11.5.6 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales by Application in 2024
11.5.7 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales by Geographic Area in 2024
11.5.8 Thermo Fisher Scientific Human NK Cell Isolation Kit SWOT Analysis
11.5.9 Thermo Fisher Scientific Recent Developments
11.6 RWD
11.6.1 RWD Corporation Information
11.6.2 RWD Business Overview
11.6.3 RWD Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.6.4 RWD Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 RWD Recent Developments
11.7 Xinxie Biotechnology
11.7.1 Xinxie Biotechnology Corporation Information
11.7.2 Xinxie Biotechnology Business Overview
11.7.3 Xinxie Biotechnology Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.7.4 Xinxie Biotechnology Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Xinxie Biotechnology Recent Developments
11.8 Jinzhun Biotechnology
11.8.1 Jinzhun Biotechnology Corporation Information
11.8.2 Jinzhun Biotechnology Business Overview
11.8.3 Jinzhun Biotechnology Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.8.4 Jinzhun Biotechnology Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Jinzhun Biotechnology Recent Developments
11.9 R&D Systems
11.9.1 R&D Systems Corporation Information
11.9.2 R&D Systems Business Overview
11.9.3 R&D Systems Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.9.4 R&D Systems Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 R&D Systems Recent Developments
11.10 BioLegend
11.10.1 BioLegend Corporation Information
11.10.2 BioLegend Business Overview
11.10.3 BioLegend Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.10.4 BioLegend Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 BioLegend Recent Developments
11.11 Proteintech Group
11.11.1 Proteintech Group Corporation Information
11.11.2 Proteintech Group Business Overview
11.11.3 Proteintech Group Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.11.4 Proteintech Group Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Proteintech Group Recent Developments
11.12 Stemery
11.12.1 Stemery Corporation Information
11.12.2 Stemery Business Overview
11.12.3 Stemery Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.12.4 Stemery Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Stemery Recent Developments
11.13 Creative Bioarray
11.13.1 Creative Bioarray Corporation Information
11.13.2 Creative Bioarray Business Overview
11.13.3 Creative Bioarray Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.13.4 Creative Bioarray Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Creative Bioarray Recent Developments
11.14 LubioScience
11.14.1 LubioScience Corporation Information
11.14.2 LubioScience Business Overview
11.14.3 LubioScience Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.14.4 LubioScience Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 LubioScience Recent Developments
11.15 Immocell
11.15.1 Immocell Corporation Information
11.15.2 Immocell Business Overview
11.15.3 Immocell Human NK Cell Isolation Kit Product Models, Descriptions and Specifications
11.15.4 Immocell Human NK Cell Isolation Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Immocell Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Human NK Cell Isolation Kit Industry Chain
12.2 Human NK Cell Isolation Kit Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Human NK Cell Isolation Kit Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Human NK Cell Isolation Kit Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human NK Cell Isolation Kit Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human NK Cell Isolation Kit Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Human NK Cell Isolation Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Human NK Cell Isolation Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Human NK Cell Isolation Kit Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human NK Cell Isolation Kit Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Human NK Cell Isolation Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Human NK Cell Isolation Kit Sales by Region (2020-2025) & (K Units)
Table 8. Global Human NK Cell Isolation Kit Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Human NK Cell Isolation Kit Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Human NK Cell Isolation Kit Sales Share by Manufacturers (2020-2025)
Table 12. Global Human NK Cell Isolation Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Human NK Cell Isolation Kit Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Human NK Cell Isolation Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human NK Cell Isolation Kit as of 2024)
Table 16. Global Human NK Cell Isolation Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Human NK Cell Isolation Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Human NK Cell Isolation Kit Manufacturing Base and Headquarters
Table 19. Global Human NK Cell Isolation Kit Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Human NK Cell Isolation Kit Sales by Type (2020-2025) & (K Units)
Table 23. Global Human NK Cell Isolation Kit Sales by Type (2026-2031) & (K Units)
Table 24. Global Human NK Cell Isolation Kit Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Human NK Cell Isolation Kit Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Human NK Cell Isolation Kit ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Human NK Cell Isolation Kit Sales by Application (2020-2025) & (K Units)
Table 29. Global Human NK Cell Isolation Kit Sales by Application (2026-2031) & (K Units)
Table 30. Human NK Cell Isolation Kit High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Human NK Cell Isolation Kit Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Human NK Cell Isolation Kit Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Human NK Cell Isolation Kit ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Human NK Cell Isolation Kit Growth Accelerators and Market Barriers
Table 37. North America Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Human NK Cell Isolation Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Human NK Cell Isolation Kit Growth Accelerators and Market Barriers
Table 40. Europe Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Human NK Cell Isolation Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Human NK Cell Isolation Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Human NK Cell Isolation Kit Growth Accelerators and Market Barriers
Table 45. Southeast Asia Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Human NK Cell Isolation Kit Investment Opportunities and Key Challenges
Table 47. Central and South America Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Human NK Cell Isolation Kit Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Human NK Cell Isolation Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. BPS Bioscience Corporation Information
Table 51. BPS Bioscience Description and Major Businesses
Table 52. BPS Bioscience Product Models, Descriptions and Specifications
Table 53. BPS Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. BPS Bioscience Sales Value Proportion by Product in 2024
Table 55. BPS Bioscience Sales Value Proportion by Application in 2024
Table 56. BPS Bioscience Sales Value Proportion by Geographic Area in 2024
Table 57. BPS Bioscience Human NK Cell Isolation Kit SWOT Analysis
Table 58. BPS Bioscience Recent Developments
Table 59. Miltenyi Biotec Corporation Information
Table 60. Miltenyi Biotec Description and Major Businesses
Table 61. Miltenyi Biotec Product Models, Descriptions and Specifications
Table 62. Miltenyi Biotec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Miltenyi Biotec Sales Value Proportion by Product in 2024
Table 64. Miltenyi Biotec Sales Value Proportion by Application in 2024
Table 65. Miltenyi Biotec Sales Value Proportion by Geographic Area in 2024
Table 66. Miltenyi Biotec Human NK Cell Isolation Kit SWOT Analysis
Table 67. Miltenyi Biotec Recent Developments
Table 68. Novus Biologicals Corporation Information
Table 69. Novus Biologicals Description and Major Businesses
Table 70. Novus Biologicals Product Models, Descriptions and Specifications
Table 71. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Novus Biologicals Sales Value Proportion by Product in 2024
Table 73. Novus Biologicals Sales Value Proportion by Application in 2024
Table 74. Novus Biologicals Sales Value Proportion by Geographic Area in 2024
Table 75. Novus Biologicals Human NK Cell Isolation Kit SWOT Analysis
Table 76. Novus Biologicals Recent Developments
Table 77. STEMCELL Technologies Corporation Information
Table 78. STEMCELL Technologies Description and Major Businesses
Table 79. STEMCELL Technologies Product Models, Descriptions and Specifications
Table 80. STEMCELL Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. STEMCELL Technologies Sales Value Proportion by Product in 2024
Table 82. STEMCELL Technologies Sales Value Proportion by Application in 2024
Table 83. STEMCELL Technologies Sales Value Proportion by Geographic Area in 2024
Table 84. STEMCELL Technologies Human NK Cell Isolation Kit SWOT Analysis
Table 85. STEMCELL Technologies Recent Developments
Table 86. Thermo Fisher Scientific Corporation Information
Table 87. Thermo Fisher Scientific Description and Major Businesses
Table 88. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 89. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 91. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 92. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 93. Thermo Fisher Scientific Human NK Cell Isolation Kit SWOT Analysis
Table 94. Thermo Fisher Scientific Recent Developments
Table 95. RWD Corporation Information
Table 96. RWD Description and Major Businesses
Table 97. RWD Product Models, Descriptions and Specifications
Table 98. RWD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. RWD Recent Developments
Table 100. Xinxie Biotechnology Corporation Information
Table 101. Xinxie Biotechnology Description and Major Businesses
Table 102. Xinxie Biotechnology Product Models, Descriptions and Specifications
Table 103. Xinxie Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Xinxie Biotechnology Recent Developments
Table 105. Jinzhun Biotechnology Corporation Information
Table 106. Jinzhun Biotechnology Description and Major Businesses
Table 107. Jinzhun Biotechnology Product Models, Descriptions and Specifications
Table 108. Jinzhun Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Jinzhun Biotechnology Recent Developments
Table 110. R&D Systems Corporation Information
Table 111. R&D Systems Description and Major Businesses
Table 112. R&D Systems Product Models, Descriptions and Specifications
Table 113. R&D Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. R&D Systems Recent Developments
Table 115. BioLegend Corporation Information
Table 116. BioLegend Description and Major Businesses
Table 117. BioLegend Product Models, Descriptions and Specifications
Table 118. BioLegend Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. BioLegend Recent Developments
Table 120. Proteintech Group Corporation Information
Table 121. Proteintech Group Description and Major Businesses
Table 122. Proteintech Group Product Models, Descriptions and Specifications
Table 123. Proteintech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Proteintech Group Recent Developments
Table 125. Stemery Corporation Information
Table 126. Stemery Description and Major Businesses
Table 127. Stemery Product Models, Descriptions and Specifications
Table 128. Stemery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Stemery Recent Developments
Table 130. Creative Bioarray Corporation Information
Table 131. Creative Bioarray Description and Major Businesses
Table 132. Creative Bioarray Product Models, Descriptions and Specifications
Table 133. Creative Bioarray Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Creative Bioarray Recent Developments
Table 135. LubioScience Corporation Information
Table 136. LubioScience Description and Major Businesses
Table 137. LubioScience Product Models, Descriptions and Specifications
Table 138. LubioScience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. LubioScience Recent Developments
Table 140. Immocell Corporation Information
Table 141. Immocell Description and Major Businesses
Table 142. Immocell Product Models, Descriptions and Specifications
Table 143. Immocell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Immocell Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Human NK Cell Isolation Kit Product Picture
Figure 2. Global Human NK Cell Isolation Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 1 x 10^8 Cells Product Picture
Figure 4. 1 x 10^9 Cells Product Picture
Figure 5. Other Product Picture
Figure 6. Global Human NK Cell Isolation Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Research Institute
Figure 8. School
Figure 9. Other
Figure 10. Human NK Cell Isolation Kit Report Years Considered
Figure 11. Global Human NK Cell Isolation Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 13. Global Human NK Cell Isolation Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Human NK Cell Isolation Kit Revenue Market Share by Region (2020-2031)
Figure 15. Global Human NK Cell Isolation Kit Sales (2020-2031) & (K Units)
Figure 16. Global Human NK Cell Isolation Kit Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Human NK Cell Isolation Kit Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Human NK Cell Isolation Kit Sales Volume Market Share in 2024
Figure 19. Global Human NK Cell Isolation Kit Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. 1 x 10^8 Cells Revenue Market Share by Manufacturer in 2024
Figure 22. 1 x 10^9 Cells Revenue Market Share by Manufacturer in 2024
Figure 23. Other Revenue Market Share by Manufacturer in 2024
Figure 24. Global Human NK Cell Isolation Kit Sales Market Share by Type (2020-2031)
Figure 25. Global Human NK Cell Isolation Kit Revenue Market Share by Type (2020-2031)
Figure 26. Global Human NK Cell Isolation Kit Sales Market Share by Application (2020-2031)
Figure 27. Global Human NK Cell Isolation Kit Revenue Market Share by Application (2020-2031)
Figure 28. North America Human NK Cell Isolation Kit Sales YoY (2020-2031) & (K Units)
Figure 29. North America Human NK Cell Isolation Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2024
Figure 31. North America Human NK Cell Isolation Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Human NK Cell Isolation Kit Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Human NK Cell Isolation Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2024
Figure 41. Europe Human NK Cell Isolation Kit Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 46. France Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Human NK Cell Isolation Kit Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Human NK Cell Isolation Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Human NK Cell Isolation Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 61. India Human NK Cell Isolation Kit Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Human NK Cell Isolation Kit Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Human NK Cell Isolation Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Human NK Cell Isolation Kit Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Human NK Cell Isolation Kit Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Human NK Cell Isolation Kit Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Human NK Cell Isolation Kit Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Human NK Cell Isolation Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Human NK Cell Isolation Kit Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Human NK Cell Isolation Kit Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Human NK Cell Isolation Kit Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Human NK Cell Isolation Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Human NK Cell Isolation Kit Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Human NK Cell Isolation Kit Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Human NK Cell Isolation Kit Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Human NK Cell Isolation Kit Revenue (2020-2025) & (US$ Million)
Figure 82. Human NK Cell Isolation Kit Industry Chain Mapping
Figure 83. Regional Human NK Cell Isolation Kit Manufacturing Base Distribution (%)
Figure 84. Global Human NK Cell Isolation Kit Production Market Share by Region (2020-2031)
Figure 85. Human NK Cell Isolation Kit Production Process
Figure 86. Regional Human NK Cell Isolation Kit Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Human NK Cell Isolation Kit in 2031?
The global market size of Human NK Cell Isolation Kit in 2031 was 470 Million USD.
Which companies rank high in the global Human NK Cell Isolation Kit market?
What was the global market size of Human NK Cell Isolation Kit in 2025?
What is the annual compound growth rate of the global Human NK Cell Isolation Kit market size from 2025 to 2031?
Which region is expected to have the highest market share?
Related Reports
Global Human NK Cell Isolation Kit Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
Global Human NK Cell Isolation Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 91
USD 4250.00
(Single User License)
Human NK Cell Isolation Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 115
USD 3950.00
(Single User License)
Global Human NK Cell Isolation Kit Market Research Report 2026
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 121
USD 2900.00
(Single User License)
Global Human NK Cell Isolation Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
Human NK Cell Isolation Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
Global Human NK Cell Isolation Kit Market Research Report 2025
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
Global and United States Human NK Cell Isolation Kit Market Report & Forecast 2024-2030
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 140
USD 4350.00
(Single User License)
Global Human NK Cell Isolation Kit Market Insights, Forecast to 2030
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published Date: 2025-01-01
Pages: 161
USD 4900.00
(Single User License)
Human NK Cell Isolation Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 111
USD 3950.00
(Single User License)
Global Human NK Cell Isolation Kit Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
USD 4900.00 (Single User License)Global Human NK Cell Isolation Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 91
USD 4250.00 (Single User License)Human NK Cell Isolation Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 115
USD 3950.00 (Single User License)Global Human NK Cell Isolation Kit Market Research Report 2026
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 121
USD 2900.00 (Single User License)Global Human NK Cell Isolation Kit Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
USD 4250.00 (Single User License)Human NK Cell Isolation Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
USD 3950.00 (Single User License)Global Human NK Cell Isolation Kit Market Research Report 2025
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-03-10
Pages: 97
USD 2900.00 (Single User License)Global and United States Human NK Cell Isolation Kit Market Report & Forecast 2024-2030
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published: 2025-01-01
Pages: 140
USD 4350.00 (Single User License)Global Human NK Cell Isolation Kit Market Insights, Forecast to 2030
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published: 2025-01-01
Pages: 161
USD 4900.00 (Single User License)Human NK Cell Isolation Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 111
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
Why This Report?
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now